Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
417 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05072639 | Preoperative Guided Imagery in Patients Undergoing Urologic Surgery | completed | N/A | 123 | University of California, San FranciscoOTHER | 1 | Oct 22, 2021 | clinicaltrials |
| NCT02508636 | Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer | terminated | Phase 2 | 11 | University of California, San FranciscoOTHER | 1 | Oct 12, 2021 | clinicaltrials |
| NCT02432001 | Radiologically Guided Biopsies of mCRPC | completed | — | 256 | University of California, San FranciscoOTHER | 2 | Oct 8, 2021 | clinicaltrials |
| NCT01316549 | Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation(HCT) | completed | — | 67 | University of California, San FranciscoOTHER | 1 | Oct 4, 2021 | clinicaltrials |
| NCT02956681 | Statewide Communication to Reach Diverse Low Income Women | completed | N/A | 88 | University of California, San FranciscoOTHER | 0 | Oct 4, 2021 | clinicaltrials |
| NCT03609814 | Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT) | completed | — | 30 | University of California, San FranciscoOTHER | 1 | Oct 4, 2021 | clinicaltrials |
| NCT03609827 | Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients | completed | — | 25 | University of California, San FranciscoOTHER | 1 | Oct 4, 2021 | clinicaltrials |
| NCT01804465 | Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer | completed | Phase 2 | 50 | University of California, San FranciscoOTHER | 1 | Aug 18, 2021 | clinicaltrials |
| NCT00911079 | Pilot Study of a Catheter-based Ultrasound Hyperthermia System | terminated | N/A | 13 | University of California, San FranciscoOTHER | 1 | Jul 7, 2021 | clinicaltrials |
| NCT03463889 | Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer | terminated | Phase 2 | 12 | University of California, San FranciscoOTHER | 1 | Jun 29, 2021 | clinicaltrials |
| NCT02947373 | Pilot Study of Safety and Toxicity of Acquiring Hyperpolarized Carbon-13 Imaging in Children With Brain Tumors | completed | Phase 1 | 10 | University of California, San FranciscoOTHER | 1 | Jun 24, 2021 | clinicaltrials |
| NCT04432818 | Digital Life Coaching for Myeloma Patients Undergoing Transplantation | completed | N/A | 17 | University of California, San FranciscoOTHER | 1 | Jun 4, 2021 | clinicaltrials |
| NCT04545697 | mHealth ElectroNic COnsultation REcording (mENCORE) in Advanced Prostate Cancer(mENCORE) | completed | N/A | 27 | University of California, San FranciscoOTHER | 1 | Jun 1, 2021 | clinicaltrials |
| NCT03849742 | Ride to Care - Quality of Life With Transportation for RT | withdrawn | N/A | 0 | University of California, San FranciscoOTHER | 0 | May 14, 2021 | clinicaltrials |
| NCT00293423 | GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma | completed | Phase 1 / Phase 2 | 96 | University of California, San FranciscoOTHER | 1 | May 13, 2021 | clinicaltrials |
| NCT02187133 | Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma | completed | Phase 1 | 10 | University of California, San FranciscoOTHER | 1 | Apr 23, 2021 | clinicaltrials |
| NCT00905060 | HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM(HeatShock) | completed | Phase 2 | 70 | University of California, San FranciscoOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT01276236 | Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) | completed | Phase 2 | 13 | University of California, San FranciscoOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT04377152 | Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer | approved for marketing | — | — | University of California, San FranciscoOTHER | 1 | Mar 1, 2021 | clinicaltrials |
| NCT01554371 | Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies | completed | Phase 1 / Phase 2 | 44 | University of California, San FranciscoOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT01840124 | Uterine Leiomyoma Treatment With Radiofrequency Ablation(ULTRA) | completed | N/A | 26 | University of California, San FranciscoOTHER | 1 | Jan 25, 2021 | clinicaltrials |
| NCT03252145 | Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device | completed | N/A | 28 | University of California, San FranciscoOTHER | 1 | Jan 15, 2021 | clinicaltrials |
| NCT02493361 | Trial of pIL-12/MK-3475 in Metastatic Melanoma | completed | Phase 2 | 24 | University of California, San FranciscoOTHER | 1 | Jan 6, 2021 | clinicaltrials |
| NCT03139331 | PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma | completed | Phase 1 | 16 | University of California, San FranciscoOTHER | 1 | Jan 5, 2021 | clinicaltrials |
| NCT04636346 | COMPASS: A Group ACT Program for Cancer Patients Treated at UCSF | completed | — | 129 | University of California, San FranciscoOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT02919111 | Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients(PSMA PreRP) | completed | Phase 2 / Phase 3 | 299 | University of California, San FranciscoOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT01687673 | Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma | completed | Phase 2 | 29 | University of California, San FranciscoOTHER | 1 | Dec 7, 2020 | clinicaltrials |
| NCT00290745 | Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ | completed | Phase 1 / Phase 2 | 79 | University of California, San FranciscoOTHER | 1 | Dec 4, 2020 | clinicaltrials |
| NCT02397408 | 11C- and 18F-Choline PET/MR Imaging for Prostate Cancer | completed | Phase 2 | 18 | University of California, San FranciscoOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT03862001 | Lung Cancer Screening: A Multilevel Intervention(LungCARE) | completed | N/A | 66 | University of California, San FranciscoOTHER | 1 | Oct 23, 2020 | clinicaltrials |
| NCT02458235 | Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation | completed | Phase 2 | 17 | University of California, San FranciscoOTHER | 1 | Oct 12, 2020 | clinicaltrials |
| NCT03528863 | Web-based Mindfulness Meditation in Reducing Distress in Participants With Metastatic Gastrointestinal Cancer and Their Caregivers | completed | N/A | 68 | University of California, San FranciscoOTHER | 1 | Oct 9, 2020 | clinicaltrials |
| NCT00751101 | Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer | terminated | Phase 2 | 24 | University of California, San FranciscoOTHER | 1 | Oct 5, 2020 | clinicaltrials |
| NCT00843531 | RAD001 and Erlotinib in Patients With Neuroendocrine Tumors | terminated | Phase 2 | 17 | University of California, San FranciscoOTHER | 1 | Sep 29, 2020 | clinicaltrials |
| NCT03524716 | Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer II(SmartPaceII) | completed | N/A | 44 | University of California, San FranciscoOTHER | 1 | Aug 27, 2020 | clinicaltrials |
| NCT01512251 | BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma | completed | Phase 1 / Phase 2 | 8 | University of California, San FranciscoOTHER | 1 | Aug 17, 2020 | clinicaltrials |
| NCT03115372 | Lay Health Worker Outreach in Increasing Colorectal Cancer Screening in Asian Americans | completed | N/A | 982 | University of California, San FranciscoOTHER | 1 | Jul 29, 2020 | clinicaltrials |
| NCT00390156 | Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors | completed | Phase 1 | 35 | University of California, San FranciscoOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT03430687 | Talimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell Carcinoma | withdrawn | Phase 1 | 0 | University of California, San FranciscoOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT02168062 | Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer | terminated | Phase 2 | 57 | University of California, San FranciscoOTHER | 1 | Jul 23, 2020 | clinicaltrials |
| NCT02451345 | Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model | completed | N/A | 58 | University of California, San FranciscoOTHER | 1 | Jul 23, 2020 | clinicaltrials |
| NCT03199911 | Topical Antibiotic Prophylaxis for Eyelids | completed | Phase 4 | 401 | University of California, San FranciscoOTHER | 1 | Jul 21, 2020 | clinicaltrials |
| NCT02395627 | Reversing Therapy Resistance With Epigenetic-Immune Modification | terminated | Phase 2 | 38 | University of California, San FranciscoOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT03045575 | Objective Assessment of Physical Activity During Chemotherapy for Breast Cancer | completed | — | 65 | University of California, San FranciscoOTHER | 1 | Jul 2, 2020 | clinicaltrials |
| NCT01036594 | Ketoconazole and Dexamethasone in Prostate Cancer(Keto/Dex) | completed | Phase 2 | 32 | University of California, San FranciscoOTHER | 1 | Jun 29, 2020 | clinicaltrials |
| NCT00985907 | Doxil® + Melphalan + Velcade (DMV) in Relapsed/Refractory Multiple Myeloma(DMV) | terminated | Phase 1 / Phase 2 | 13 | University of California, San FranciscoOTHER | 1 | Jun 17, 2020 | clinicaltrials |
| NCT00295867 | Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer | completed | Phase 2 | 45 | University of California, San FranciscoOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT01377532 | Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma | approved for marketing | — | — | University of California, San FranciscoOTHER | 1 | May 6, 2020 | clinicaltrials |
| NCT00632827 | Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak) | terminated | Phase 2 | 21 | University of California, San FranciscoOTHER | 1 | Apr 27, 2020 | clinicaltrials |
| NCT00622440 | Treatment of Anal High-grade Squamous Intraepithelial Lesions (HSIL) Through Use of a Chinese Herbal Topical Cream(AIJP) | completed | Phase 2 | 70 | University of California, San FranciscoOTHER | 1 | Apr 24, 2020 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials